Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
Figuring out how T cells interpret signals
St. Jude scientists are studying how cytokines that promote inflammatory responses affect T cells.
-
St. Jude acquires a facility dog for employee support
Rosalie, a 60-pound golden retriever, joins St. Jude as a facility dog in the Staff Resilience Center dedicated to supporting employees.
-
Genetic rescue, a ‘natural gene therapy,’ suggests possible new approach to pediatric MDS
St. Jude and the European Working Group of MDS in Childhood report results of a landmark study of the blood disorders known as pediatric myelodysplastic syndromes.
-
David Rogers honored by American College of Clinical Pharmacy
The chair of St. Jude Pharmacy/Pharmaceutical Sciences will receive 2 top science honors from ACCP at its annual meeting. It is highly unusual for both to be presented to the same person in the same year.
-
St. Jude names Shannon Dean, M.D., as chief medical information officer
Shannon Dean to help oversee launch of hospital’s new electronic health record as the hospital enhances the patient experience.
-
Control of rhabdomyosarcoma cell identity provides clues to possible treatments
Findings from St. Jude Children’s Research Hospital show how control of transcription factors by a common tumor suppressor gene may provide a therapeutic opportunity in a type of childhood cancer.